About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Part 1: Emerging Concepts
Nanoparticles may soon be used to transport diagnostic and therapeutic drugs to targeted sites not normally accessible, thereby improving treatment and reducing costs. Further research is still needed to establish the efficacy and safety of these nanomaterials.
C. Lee Ventola, MS
Role of Alvimopan (Entereg) in Gastrointestinal Recovery and Hospital Length of Stay After Bowel Resection
A retrospective chart review revealed that patients receiving alvimopan after bowel surgery had faster recovery times, better surgical care, and lower costs of care compared with patients who did not receive the drug.
Shan Wang, PharmD, RPh; Neal Shah, PharmD Candidate; Jessin Philip, PharmD, RPh; Tom Caraccio, PharmD; Martin Feuerman, MS; and Brian Malone, MS, RPh
Selected topics include targeted and chemotherapeutic agents (darafenib, trametinib), immunotherapies (ipilimumab, T-VEC, Rose Bengal), and the
continuing role of single-agent and combination chemotherapy.
Makena or Compounded 17P?; Clarification on Hydrocodone (Zohydro)
Automated dispensing cabinets have had a mixed record on improving drug safety.
Matthew Grissinger, RPh, FASCP
How Directly Will They Be Affected?
Pharmacists will need to become well versed in the FDA’s REMS for opioids.
FDA approvals, drug indications, and updates
Lorcaserin (Belviq), an appetite suppressant; pertuzumab (Perjeta) for HER-2–positive metastatic breast cancer; MenHibrix vaccine for meningococcal infections and influenza; icosapent ethyl (Vascepa) for reducing triglycerides; and aclidinium inhalation (Tudorza) powder for bronchospasm in COPD
Marvin M. Goldenberg, PhD, RPh, MS
Serious Side Effects and a Hefty Price Tag May Limit Its Use